Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis ?
1Pathology Laboratory, University of Athens, Aretaieion Hospital, Athens, Greece
22nd Clinic of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, Athens, Greece
*Corresponding Author(s): A. Kondi-Pafiti E-mail: akondi@med.uoa.gr
Purpose: To further study the clinicopathological features of synchronous ovarian and endometrial carcinomas. Methods: We retrospectively studied all cases of synchronous ovarian and endometrial carcinomas diagnosed in our laboratory over the last 15-year period. The pathological findings were correlated with the clinical records of the patients. Results: Seven cases of synchronous primary ovarian and endometrial carcinomas were retrieved. The most common presenting symptom was abnormal vaginal bleeding (5 cases. 71.4%). Five patients (71.4%) were postmenopausal and two (28.6%) were nulliparous. All seven patients had Stage I ovarian and endometrial carcinomas of endometrioid histology. Moreover, in all seven ovarian carcinomas endometriosis foci were observed, while atypical endometriosis was found in four of them. With the exception of one patient, who received adjuvant postoperative radiation, all remaining patients were treated with surgery alone. All patients were alive and free of disease at completion of the study. Conclusion: The correct classification of synchronous primary ovarian and endometrial carcinomas is often problematic because of the frequent confusion with their metastatic counterparts. Although the exact etiology remains unclear, endometriosis seems to be a major risk factor for their development.
Ovarian; Endometrial; Synchronous carcinomas; Endometriosis
A. Kondi-Pafiti,D. Grapsa,A. Liapis,K. Papadias,E. Kairi-Vassilatou,D. Hasiakos. Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis ?. European Journal of Gynaecological Oncology. 2008. 29(3);256-259.
[1] Zaino R., Whitney C., Brady M.F., DeGeest K., Burger R.A., Buller R.E.: “Simultaneously detected endometrial and ovarian carcinomas – a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study”. Gynecol. Oncol., 2001, 83, 365.
[2] Sheu B.C., Lin H.H., Chen C.K., Shun C.T., Huang S.C.: “Synchronous primary carcinomas of the endometrium and ovary”. Int. J. Gynaecol. Obstet., 1995, 51, 141.
[3] Ulbright T.M., Roth L.M: “Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases”. Hum. Pathol., 1985, 16, 28.
[4] Scully R.E., Young R.H., Clement P.B.: “Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. Atlas of Tumor Pathology”. Washington, AFIP, 1998.
[5] Varma R., Rollason T., Gupta J.K., Maher E.R.: “Endometriosis and the metastatic process”. Reproduction, 2004, 127, 293.
[6] Brinton L.A., Gridley G., Persson I., Baron J., Bergqvist A.: “Cancer risk after a hospital diagnosis of endometriosis”. Am. J. Obstet. Gynecol., 1997, 176, 572.
[7] Erzen M., Kovacic J.: “Relationship between endometriosis and ovarian cancer”. Eur. J. Gynaecol. Oncol., 1998, 19, 553.
[8] Stern R.C., Dash R., Bentley R.C., Snyder M.J., Haney A.F., Robboy S.J.: “Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types”. Int. J. Gynecol. Pathol., 2001, 20, 133.
[9] Soliman P.T., Slomovitz B.M., Broaddus R.R., Sun C.C., Oh J.C., Eifel P.J. et al.: “Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases”. Gynecol. Oncol., 2004, 94, 456.
[10] Castro I.M., Connell P.P., Waggoner S., Rotmensch J., Mundt A.J.: “Synchronous ovarian and endometrial malignancies”. Am. J. Clin. Oncol., 2000, 23, 521.
[11] Pearl M.L., Johnston C.M., Frank T.S., Roberts J.A.: “Synchronous dual primary ovarian and endometrial carcinomas”. Int. J. Gynaecol. Obstet., 1993, 43, 305.
[12] Ayhan A., Yalcin O.T., Tuncer Z.S., Gurgan T., Kucukali T.: “Synchronous primary malignancies of the female genital tract”. Eur. J. Obstet. Gynecol. Reprod. Biol., 1992, 45, 63.
[13] Eifel P., Hendrickson M., Ross J., Ballon S., Mantinez A., Kempson R.: “Simultaneous presentation of carcinoma involving the ovary and the uterine corpus”. Cancer, 1982, 50, 163.
[14] Choo Y.C., Naylor B.: “Multiple primary neoplasms of the ovary and uterus”. Int. J. Gynaecol. Obstet., 1982, 20, 237.
[15] Jambhekar N.A., Sampat M.B.: “Simultaneous endometrioid carcinoma of the uterine corpus and ovary: a clinicopathologic study of 15 cases”. J. Surg. Oncol.. 1988, 37, 2023.
[16] Maneschi M., Maneschi F., Geraci P.: “Surgical pathological staging for carcinoma of the endometrium”. Eur. J. Gynaecol. Oncol., 1992, 13, 30.
[17] Wolfson A., Sightler S., Markoe A., Schwade J., Averette H.E., Ganzei P. et al: “The prognostic significance of surgical staging for carcinoma of the endometrium”. Gynecol. Oncol., 1992, 45, 142.
[18] Prat J., Matias-Guiu Z., Barreto J.: “Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical and DNA flow cytometric study of 18 cases”. Cancer, 1991, 68, 2455.
[19] Symonds D.A., Johnson D.P., Wheeles C.R.: “Feulgen cytometry in simultaneous endometrial and ovarian carcinoma”. Cancer, 1988, 61, 2511.
[20] Furlan D., Carnevali I., Marconini B., Cerutti R., Dainese E., Capella C. et al.: “The high frequency of De novo promoter methylation in synchronous primary endometrial and ovarian carcinomas”. Clin. Cancer. Res.. 2006, 12, 3329.
[21] Matias-Guiu X., Prat J.: “Molecular pathology of ovarian carcinomas”. Virchows. Arch., 1998, 433, 103.
[22] Emmert-Buck M.R., Chuaqui R., Zhuang Z., Nogales F., Liotta L.A., Merino M.J.: “Molecular analysis of synchronous uterine and ovarian endometrioid tumors”. Int. J. Gynecol. Pathol.. 1997, 16, 143.
[23] Anneger J.F., Malkasian G.D.: “Patterns of other neoplasms in patients with endometrial carcinoma”. Cancer, 1981, 48, 856.
[24] Czernobilsky B., Silverman B.D., Mikuta J.J.: “Endometrioid carcinoma of the ovary”. Cancer, 1970, 26, 1141.
[25] Lauchlan S.C.: “Conceptual unity of the Mullerian system”. Cancer, 1968, 22, 601.
[26] Lauchlan S.C.: “The secondary Mullerian system”. Obstet. Gynecol., 1972, 27, 133.
[27] Prowse A.H., Manek S., Varma R., Liu Z., Godwin A.K., Maher E.R. et al.: “Molecular genetic evidence that endometriosis is a precursor of ovarian cancer”. Int. J. Cancer, 2006, 119, 558.
[28] Fukunaga M., Nomura K., Ishikawa E., Ushigome S.: “Ovarian atypical endometriosis: its close association with malignant epithelial tumours”. Histopathology, 1997, 30, 249.
[29] Ogawa S., Kaku T., Amada S., Kobayashi H., Hirakawa T., Ariyoshi K. et al.: “Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study”. Gynecol. Oncol., 2000, 77, 298.
[30 ]Seidman J.D.: “Prognostic importance of hyperplasia and atypia in endometriosis”. Int. J. Gynecol. Pathol., 1996, 15, 1.
[31] Campbell J.S., Magner D., Fournier P.: “Adenoacanthomas of ovary and uterus occurring as coexistent or sequential primary neoplasms”. Cancer, 1961, 14, 817.
[32] Scully R.E., Richardson G.S., Barlow J.F.: “The development of malignancy in endometriosis”. Clin. Obstet. Gynecol., 1966, 9, 384.
Web of Science (WOS) (On Hold)
Journal Citation Reports/Science Edition
Google Scholar
JournalSeek
Top